Abstract 250: Identifying drivers of liver cancer using CRISPR activation screening in vivo
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-250
Abstract: Hepatocellular Carcinoma (HCC) is the most prevalent type of liver cancer and the third leading cause of cancer deaths worldwide. Drugs approved for first- and second-line therapy extend survival by only several months. Hence, there… read more here.
Keywords: liver cancer; activation; hcc; grnas targeting ... See more keywords